---
title: "YUYUE MEDICAL: An AED product has obtained EU MDR certification"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/240358784.md"
description: "YUYUE MEDICAL's subsidiary Metrax GmbH recently received notification from TÜV SÜD Product Service GmbH that its application for an Automated External Defibrillator (AED) has obtained the Class III Medical Device CE certification in compliance with the EU Medical Device Regulation (MDR) No. 2017/745. The product, HeartSave myPAD series, is the company's latest generation of smart products"
datetime: "2025-05-15T11:13:10.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/240358784.md)
  - [en](https://longbridge.com/en/news/240358784.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/240358784.md)
---

# YUYUE MEDICAL: An AED product has obtained EU MDR certification

According to the Zhitong Finance APP, YUYUE MEDICAL (002223.SZ) announced that its controlling subsidiary's subsidiary, Metrax GmbH, recently received a notification from TÜV SÜD Product Service GmbH. The automatic external defibrillator (referred to as "AED") applied for by Metrax GmbH has obtained the Class III medical device CE certification in accordance with the EU Medical Device Regulation No. 2017/745 (referred to as "MDR"). The certified AED product HeartSave myPAD series is the company's latest generation of smart products

### Related Stocks

- [002223.CN](https://longbridge.com/en/quote/002223.CN.md)

## Related News & Research

- [BREAKINGVIEWS-Trumps laugh all the way to the bank charter](https://longbridge.com/en/news/296224512.md)
- [Top Economist Warns Trump’s Immigration Policies Are Hurting American Workers: ‘Only Reason Economy Isn’t in Complete Shambles Is...’](https://longbridge.com/en/news/296087349.md)
- [11:06 ETEndurance Named to Inc. 5000 for 11th Time, Continuing National Growth](https://longbridge.com/en/news/296124358.md)
- [11:33 ETDuPage Regional Office of Education Expands Student Health and Wellness Supports Ahead of New School Year](https://longbridge.com/en/news/296126704.md)
- [Dicot Pharma submits EU clinical trial application for LIB-01 phase 2b study](https://longbridge.com/en/news/296068059.md)